Macrogenics Stock Investor Sentiment
| MGNX Stock | USD 14.37 1.33 8.47% |
Slightly above 58% of MacroGenics' investor base is looking to short. The analysis of the overall investor sentiment regarding MacroGenics suggests that many traders are alarmed. MacroGenics' investor sentiment overview provides quick insight into current market opportunities from investing in MacroGenics. The current market sentiment, together with MacroGenics' historical and current headlines, can help investors time the market. In addition, many technical investors use MacroGenics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
MacroGenics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of MacroGenics daily returns and investor perception about the current price of MacroGenics as well as its diversification or hedging effects on your existing portfolios.
MacroGenics |
MacroGenics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards MacroGenics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
MacroGenics Maximum Pain Price across 2024-05-17 Option Contracts
MacroGenics' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of MacroGenics close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of MacroGenics' options.
Far too much social signal, news, headlines, and media speculation about MacroGenics that are available to investors today. That information is available publicly through MacroGenics media outlets and privately through word of mouth or via MacroGenics internal channels. However, regardless of the origin, that massive amount of MacroGenics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MacroGenics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MacroGenics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MacroGenics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MacroGenics alpha.
MacroGenics Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | MacroGenics, Inc. Surges 27 percent Yet Its Low PS Is No Reason For Excitement | 02/28/2024 |
2 | Disposition of 10875 shares by Jeffrey Peters of MacroGenics at 11.5 subject to Rule 16b-3 | 03/06/2024 |
3 | MacroGenics Inc earnings matched, revenue topped estimates | 03/07/2024 |
4 | MGNX Stock Earnings Macrogenics Misses EPS for Q4 2023 | 03/08/2024 |
5 | MacroGenics, Inc. Q4 2023 Earnings Call Transcript | 03/14/2024 |
6 | Acquisition by Jeffrey Peters of 54376 shares of MacroGenics at 11.5 subject to Rule 16b-3 | 03/25/2024 |
7 | MacroGenics reports progress in prostate cancer study | 04/03/2024 |
8 | Stifel keeps Buy on MacroGenics stock, confidence in vobra-duos development path | 04/04/2024 |
9 | MacroGenics shares upgraded on positive Phase II trial data | 04/09/2024 |
10 | Were Hopeful That MacroGenics Will Use Its Cash Wisely | 04/19/2024 |
Check out MacroGenics Hype Analysis, MacroGenics Correlation and MacroGenics Performance. For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for MacroGenics Stock analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is MacroGenics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MacroGenics. If investors know MacroGenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MacroGenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.949 | Quarterly Revenue Growth (0.85) | Return On Assets (0.36) | Return On Equity (0.06) |
The market value of MacroGenics is measured differently than its book value, which is the value of MacroGenics that is recorded on the company's balance sheet. Investors also form their own opinion of MacroGenics' value that differs from its market value or its book value, called intrinsic value, which is MacroGenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MacroGenics' market value can be influenced by many factors that don't directly affect MacroGenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MacroGenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if MacroGenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MacroGenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.